nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—SCN5A—dilated cardiomyopathy	0.34	0.715	CbGaD
Propafenone—Quinapril—Lisinopril—dilated cardiomyopathy	0.148	0.512	CrCrCtD
Propafenone—Benazepril—Lisinopril—dilated cardiomyopathy	0.141	0.488	CrCrCtD
Propafenone—ADRB1—dilated cardiomyopathy	0.135	0.284	CbGaD
Propafenone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0412	0.409	CbGbCtD
Propafenone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0317	0.314	CbGbCtD
Propafenone—ABCB1—Spironolactone—dilated cardiomyopathy	0.0279	0.277	CbGbCtD
Propafenone—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0195	0.282	CbGeAlD
Propafenone—KCNH2—purkinje fiber—dilated cardiomyopathy	0.012	0.173	CbGeAlD
Propafenone—SCN5A—endocardium—dilated cardiomyopathy	0.01	0.145	CbGeAlD
Propafenone—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0095	0.138	CbGeAlD
Propafenone—KCNH2—endocardium—dilated cardiomyopathy	0.00616	0.0893	CbGeAlD
Propafenone—CYP2C9—cardial valve—dilated cardiomyopathy	0.00501	0.0726	CbGeAlD
Propafenone—Breath sounds abnormal—Lisinopril—dilated cardiomyopathy	0.00183	0.0293	CcSEcCtD
Propafenone—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.00154	0.0247	CcSEcCtD
Propafenone—Diuresis—Furosemide—dilated cardiomyopathy	0.0015	0.0241	CcSEcCtD
Propafenone—Breast pain—Spironolactone—dilated cardiomyopathy	0.000983	0.0158	CcSEcCtD
Propafenone—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.000921	0.0148	CcSEcCtD
Propafenone—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.000843	0.0122	CbGeAlD
Propafenone—SCN5A—myocardium—dilated cardiomyopathy	0.000793	0.0115	CbGeAlD
Propafenone—Bursitis—Lisinopril—dilated cardiomyopathy	0.000724	0.0116	CcSEcCtD
Propafenone—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.000712	0.0114	CcSEcCtD
Propafenone—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.000679	0.00985	CbGeAlD
Propafenone—Thrombosis—Furosemide—dilated cardiomyopathy	0.000659	0.0106	CcSEcCtD
Propafenone—Blister—Furosemide—dilated cardiomyopathy	0.000647	0.0104	CcSEcCtD
Propafenone—ADRB1—myocardium—dilated cardiomyopathy	0.000639	0.00926	CbGeAlD
Propafenone—Cholestasis—Furosemide—dilated cardiomyopathy	0.000614	0.00986	CcSEcCtD
Propafenone—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.000602	0.00966	CcSEcCtD
Propafenone—Carvedilol—NPPB—dilated cardiomyopathy	0.000589	0.146	CrCbGaD
Propafenone—Carvedilol—GJA1—dilated cardiomyopathy	0.000589	0.146	CrCbGaD
Propafenone—Ataxia—Spironolactone—dilated cardiomyopathy	0.000585	0.00939	CcSEcCtD
Propafenone—Glycosuria—Furosemide—dilated cardiomyopathy	0.000576	0.00924	CcSEcCtD
Propafenone—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00056	0.00899	CcSEcCtD
Propafenone—SCN5A—heart—dilated cardiomyopathy	0.000554	0.00803	CbGeAlD
Propafenone—Gastritis—Spironolactone—dilated cardiomyopathy	0.000551	0.00884	CcSEcCtD
Propafenone—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000533	0.00854	CcSEcCtD
Propafenone—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000519	0.00752	CbGeAlD
Propafenone—Gout—Furosemide—dilated cardiomyopathy	0.0005	0.00802	CcSEcCtD
Propafenone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000495	0.00795	CcSEcCtD
Propafenone—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00049	0.00786	CcSEcCtD
Propafenone—KCNH2—myocardium—dilated cardiomyopathy	0.000488	0.00707	CbGeAlD
Propafenone—Throat sore—Lisinopril—dilated cardiomyopathy	0.000486	0.00779	CcSEcCtD
Propafenone—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.000486	0.00779	CcSEcCtD
Propafenone—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000481	0.00772	CcSEcCtD
Propafenone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00048	0.0077	CcSEcCtD
Propafenone—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000474	0.00687	CbGeAlD
Propafenone—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000473	0.00759	CcSEcCtD
Propafenone—Renal failure—Spironolactone—dilated cardiomyopathy	0.000471	0.00756	CcSEcCtD
Propafenone—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000457	0.00733	CcSEcCtD
Propafenone—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000457	0.00733	CcSEcCtD
Propafenone—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000448	0.00718	CcSEcCtD
Propafenone—ADRB1—heart—dilated cardiomyopathy	0.000446	0.00647	CbGeAlD
Propafenone—Breast pain—Lisinopril—dilated cardiomyopathy	0.000401	0.00644	CcSEcCtD
Propafenone—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000398	0.00639	CcSEcCtD
Propafenone—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000393	0.0063	CcSEcCtD
Propafenone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000389	0.00625	CcSEcCtD
Propafenone—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000387	0.00622	CcSEcCtD
Propafenone—Polyuria—Furosemide—dilated cardiomyopathy	0.000386	0.00619	CcSEcCtD
Propafenone—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000385	0.00618	CcSEcCtD
Propafenone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000385	0.00618	CcSEcCtD
Propafenone—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000381	0.00553	CbGeAlD
Propafenone—Alopecia—Spironolactone—dilated cardiomyopathy	0.00038	0.0061	CcSEcCtD
Propafenone—Oliguria—Lisinopril—dilated cardiomyopathy	0.00038	0.00609	CcSEcCtD
Propafenone—Deafness—Furosemide—dilated cardiomyopathy	0.000378	0.00607	CcSEcCtD
Propafenone—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000378	0.00607	CcSEcCtD
Propafenone—Gout—Lisinopril—dilated cardiomyopathy	0.000375	0.00601	CcSEcCtD
Propafenone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00036	0.00578	CcSEcCtD
Propafenone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000354	0.00568	CcSEcCtD
Propafenone—Neck pain—Lisinopril—dilated cardiomyopathy	0.000354	0.00568	CcSEcCtD
Propafenone—Purpura—Furosemide—dilated cardiomyopathy	0.000351	0.00564	CcSEcCtD
Propafenone—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00035	0.00562	CcSEcCtD
Propafenone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000348	0.00558	CcSEcCtD
Propafenone—KCNH2—heart—dilated cardiomyopathy	0.00034	0.00494	CbGeAlD
Propafenone—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00034	0.00545	CcSEcCtD
Propafenone—Wheezing—Lisinopril—dilated cardiomyopathy	0.00034	0.00545	CcSEcCtD
Propafenone—Malaise—Spironolactone—dilated cardiomyopathy	0.000338	0.00542	CcSEcCtD
Propafenone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000335	0.00538	CcSEcCtD
Propafenone—Urinary retention—Furosemide—dilated cardiomyopathy	0.000322	0.00517	CcSEcCtD
Propafenone—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000317	0.00509	CcSEcCtD
Propafenone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000315	0.00506	CcSEcCtD
Propafenone—Dehydration—Furosemide—dilated cardiomyopathy	0.000315	0.00505	CcSEcCtD
Propafenone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000309	0.00496	CcSEcCtD
Propafenone—Confusional state—Spironolactone—dilated cardiomyopathy	0.000308	0.00495	CcSEcCtD
Propafenone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000308	0.00494	CcSEcCtD
Propafenone—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000307	0.00492	CcSEcCtD
Propafenone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000305	0.00489	CcSEcCtD
Propafenone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000299	0.00481	CcSEcCtD
Propafenone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000299	0.00479	CcSEcCtD
Propafenone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000295	0.00473	CcSEcCtD
Propafenone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000293	0.00471	CcSEcCtD
Propafenone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000292	0.00469	CcSEcCtD
Propafenone—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000291	0.00422	CbGeAlD
Propafenone—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000291	0.00466	CcSEcCtD
Propafenone—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00029	0.00465	CcSEcCtD
Propafenone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000287	0.0046	CcSEcCtD
Propafenone—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000287	0.0046	CcSEcCtD
Propafenone—CYP2C9—heart—dilated cardiomyopathy	0.000277	0.00401	CbGeAlD
Propafenone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000274	0.0044	CcSEcCtD
Propafenone—Somnolence—Spironolactone—dilated cardiomyopathy	0.000272	0.00436	CcSEcCtD
Propafenone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00027	0.00434	CcSEcCtD
Propafenone—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000268	0.0043	CcSEcCtD
Propafenone—Esmolol—ADRB1—dilated cardiomyopathy	0.000267	0.066	CrCbGaD
Propafenone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000264	0.00424	CcSEcCtD
Propafenone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000264	0.00424	CcSEcCtD
Propafenone—Bevantolol—ADRB1—dilated cardiomyopathy	0.000263	0.0652	CrCbGaD
Propafenone—Arthritis—Lisinopril—dilated cardiomyopathy	0.000261	0.00419	CcSEcCtD
Propafenone—Drowsiness—Furosemide—dilated cardiomyopathy	0.000261	0.00419	CcSEcCtD
Propafenone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000259	0.00416	CcSEcCtD
Propafenone—Renal failure—Furosemide—dilated cardiomyopathy	0.000256	0.00412	CcSEcCtD
Propafenone—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000255	0.00409	CcSEcCtD
Propafenone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000254	0.00408	CcSEcCtD
Propafenone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000252	0.00404	CcSEcCtD
Propafenone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000252	0.00404	CcSEcCtD
Propafenone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000247	0.00396	CcSEcCtD
Propafenone—Bopindolol—ADRB1—dilated cardiomyopathy	0.000244	0.0604	CrCbGaD
Propafenone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000243	0.00391	CcSEcCtD
Propafenone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000243	0.0039	CcSEcCtD
Propafenone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000242	0.00388	CcSEcCtD
Propafenone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000242	0.00388	CcSEcCtD
Propafenone—Ataxia—Lisinopril—dilated cardiomyopathy	0.000239	0.00383	CcSEcCtD
Propafenone—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000238	0.00382	CcSEcCtD
Propafenone—Dehydration—Lisinopril—dilated cardiomyopathy	0.000236	0.00379	CcSEcCtD
Propafenone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000232	0.00372	CcSEcCtD
Propafenone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000231	0.00371	CcSEcCtD
Propafenone—Salmeterol—ADRB2—dilated cardiomyopathy	0.00023	0.057	CrCbGaD
Propafenone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00023	0.00368	CcSEcCtD
Propafenone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00023	0.00368	CcSEcCtD
Propafenone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000229	0.00367	CcSEcCtD
Propafenone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000226	0.00362	CcSEcCtD
Propafenone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000225	0.00362	CcSEcCtD
Propafenone—Gastritis—Lisinopril—dilated cardiomyopathy	0.000225	0.00361	CcSEcCtD
Propafenone—Esmolol—ADRB2—dilated cardiomyopathy	0.000224	0.0555	CrCbGaD
Propafenone—Quinapril—ACE—dilated cardiomyopathy	0.000222	0.055	CrCbGaD
Propafenone—Bevantolol—ADRB2—dilated cardiomyopathy	0.000221	0.0548	CrCbGaD
Propafenone—Influenza—Lisinopril—dilated cardiomyopathy	0.00022	0.00352	CcSEcCtD
Propafenone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000219	0.00351	CcSEcCtD
Propafenone—Tinnitus—Furosemide—dilated cardiomyopathy	0.000218	0.0035	CcSEcCtD
Propafenone—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000217	0.00349	CcSEcCtD
Propafenone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000216	0.00347	CcSEcCtD
Propafenone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000215	0.00345	CcSEcCtD
Propafenone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000214	0.00343	CcSEcCtD
Propafenone—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000214	0.00343	CcSEcCtD
Propafenone—Angiopathy—Furosemide—dilated cardiomyopathy	0.000213	0.00341	CcSEcCtD
Propafenone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000212	0.00339	CcSEcCtD
Propafenone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000209	0.00336	CcSEcCtD
Propafenone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000209	0.00336	CcSEcCtD
Propafenone—Dysuria—Lisinopril—dilated cardiomyopathy	0.000205	0.00329	CcSEcCtD
Propafenone—Bopindolol—ADRB2—dilated cardiomyopathy	0.000205	0.0508	CrCbGaD
Propafenone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000204	0.00327	CcSEcCtD
Propafenone—Erythema—Furosemide—dilated cardiomyopathy	0.000204	0.00327	CcSEcCtD
Propafenone—Malnutrition—Furosemide—dilated cardiomyopathy	0.000204	0.00327	CcSEcCtD
Propafenone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000202	0.00325	CcSEcCtD
Propafenone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000202	0.00324	CcSEcCtD
Propafenone—Flatulence—Furosemide—dilated cardiomyopathy	0.000201	0.00322	CcSEcCtD
Propafenone—Weight increased—Lisinopril—dilated cardiomyopathy	0.0002	0.00321	CcSEcCtD
Propafenone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0002	0.0032	CcSEcCtD
Propafenone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000199	0.00319	CcSEcCtD
Propafenone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000198	0.00318	CcSEcCtD
Propafenone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000196	0.00315	CcSEcCtD
Propafenone—Depression—Lisinopril—dilated cardiomyopathy	0.000195	0.00313	CcSEcCtD
Propafenone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000194	0.00312	CcSEcCtD
Propafenone—Benazepril—ACE—dilated cardiomyopathy	0.000193	0.0479	CrCbGaD
Propafenone—Rash—Spironolactone—dilated cardiomyopathy	0.000193	0.00309	CcSEcCtD
Propafenone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000193	0.00309	CcSEcCtD
Propafenone—Renal failure—Lisinopril—dilated cardiomyopathy	0.000192	0.00309	CcSEcCtD
Propafenone—Vision blurred—Furosemide—dilated cardiomyopathy	0.000192	0.00308	CcSEcCtD
Propafenone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000192	0.00308	CcSEcCtD
Propafenone—Headache—Spironolactone—dilated cardiomyopathy	0.000192	0.00307	CcSEcCtD
Propafenone—Jaundice—Lisinopril—dilated cardiomyopathy	0.000191	0.00306	CcSEcCtD
Propafenone—Anaemia—Furosemide—dilated cardiomyopathy	0.000188	0.00302	CcSEcCtD
Propafenone—Haematuria—Lisinopril—dilated cardiomyopathy	0.000187	0.003	CcSEcCtD
Propafenone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000185	0.00297	CcSEcCtD
Propafenone—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000185	0.00296	CcSEcCtD
Propafenone—Vertigo—Furosemide—dilated cardiomyopathy	0.000183	0.00294	CcSEcCtD
Propafenone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000183	0.00293	CcSEcCtD
Propafenone—Leukopenia—Furosemide—dilated cardiomyopathy	0.000183	0.00293	CcSEcCtD
Propafenone—Nausea—Spironolactone—dilated cardiomyopathy	0.000182	0.00292	CcSEcCtD
Propafenone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000179	0.00287	CcSEcCtD
Propafenone—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000176	0.00283	CcSEcCtD
Propafenone—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000176	0.00282	CcSEcCtD
Propafenone—Labetalol—ADRB1—dilated cardiomyopathy	0.000175	0.0433	CrCbGaD
Propafenone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000174	0.00278	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000172	0.00277	CcSEcCtD
Propafenone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000172	0.00276	CcSEcCtD
Propafenone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00017	0.00272	CcSEcCtD
Propafenone—Confusional state—Furosemide—dilated cardiomyopathy	0.000168	0.00269	CcSEcCtD
Propafenone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000164	0.00263	CcSEcCtD
Propafenone—Shock—Furosemide—dilated cardiomyopathy	0.000164	0.00263	CcSEcCtD
Propafenone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000163	0.00262	CcSEcCtD
Propafenone—Flushing—Lisinopril—dilated cardiomyopathy	0.000163	0.00262	CcSEcCtD
Propafenone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000163	0.00261	CcSEcCtD
Propafenone—Skin disorder—Furosemide—dilated cardiomyopathy	0.000162	0.00259	CcSEcCtD
Propafenone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000161	0.00258	CcSEcCtD
Propafenone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000159	0.00256	CcSEcCtD
Propafenone—Anorexia—Furosemide—dilated cardiomyopathy	0.000159	0.00255	CcSEcCtD
Propafenone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000158	0.00254	CcSEcCtD
Propafenone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000157	0.00252	CcSEcCtD
Propafenone—Hypotension—Furosemide—dilated cardiomyopathy	0.000156	0.0025	CcSEcCtD
Propafenone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000155	0.00249	CcSEcCtD
Propafenone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000154	0.00247	CcSEcCtD
Propafenone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000153	0.00245	CcSEcCtD
Propafenone—Erythema—Lisinopril—dilated cardiomyopathy	0.000153	0.00245	CcSEcCtD
Propafenone—Flatulence—Lisinopril—dilated cardiomyopathy	0.000151	0.00242	CcSEcCtD
Propafenone—Tension—Lisinopril—dilated cardiomyopathy	0.00015	0.00241	CcSEcCtD
Propafenone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00015	0.0024	CcSEcCtD
Propafenone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000149	0.0024	CcSEcCtD
Propafenone—ABCB1—heart—dilated cardiomyopathy	0.000149	0.00217	CbGeAlD
Propafenone—Nervousness—Lisinopril—dilated cardiomyopathy	0.000149	0.00238	CcSEcCtD
Propafenone—Somnolence—Furosemide—dilated cardiomyopathy	0.000148	0.00237	CcSEcCtD
Propafenone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000147	0.00236	CcSEcCtD
Propafenone—Labetalol—ADRB2—dilated cardiomyopathy	0.000147	0.0364	CrCbGaD
Propafenone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000145	0.00232	CcSEcCtD
Propafenone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000144	0.00231	CcSEcCtD
Propafenone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000144	0.00231	CcSEcCtD
Propafenone—Fatigue—Furosemide—dilated cardiomyopathy	0.000143	0.0023	CcSEcCtD
Propafenone—Tremor—Lisinopril—dilated cardiomyopathy	0.000143	0.0023	CcSEcCtD
Propafenone—Constipation—Furosemide—dilated cardiomyopathy	0.000142	0.00228	CcSEcCtD
Propafenone—Pain—Furosemide—dilated cardiomyopathy	0.000142	0.00228	CcSEcCtD
Propafenone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000142	0.00228	CcSEcCtD
Propafenone—Anaemia—Lisinopril—dilated cardiomyopathy	0.000141	0.00227	CcSEcCtD
Propafenone—Malaise—Lisinopril—dilated cardiomyopathy	0.000138	0.00221	CcSEcCtD
Propafenone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000137	0.00221	CcSEcCtD
Propafenone—Syncope—Lisinopril—dilated cardiomyopathy	0.000137	0.0022	CcSEcCtD
Propafenone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000137	0.0022	CcSEcCtD
Propafenone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000137	0.0022	CcSEcCtD
Propafenone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000136	0.00218	CcSEcCtD
Propafenone—Palpitations—Lisinopril—dilated cardiomyopathy	0.000135	0.00217	CcSEcCtD
Propafenone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000134	0.00216	CcSEcCtD
Propafenone—Cough—Lisinopril—dilated cardiomyopathy	0.000134	0.00214	CcSEcCtD
Propafenone—Urticaria—Furosemide—dilated cardiomyopathy	0.000132	0.00212	CcSEcCtD
Propafenone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000132	0.00211	CcSEcCtD
Propafenone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000132	0.00211	CcSEcCtD
Propafenone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00013	0.00209	CcSEcCtD
Propafenone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00013	0.00209	CcSEcCtD
Propafenone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00013	0.00208	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000129	0.00208	CcSEcCtD
Propafenone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000129	0.00206	CcSEcCtD
Propafenone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000127	0.00204	CcSEcCtD
Propafenone—Confusional state—Lisinopril—dilated cardiomyopathy	0.000126	0.00202	CcSEcCtD
Propafenone—Oedema—Lisinopril—dilated cardiomyopathy	0.000125	0.002	CcSEcCtD
Propafenone—Infection—Lisinopril—dilated cardiomyopathy	0.000124	0.00199	CcSEcCtD
Propafenone—Shock—Lisinopril—dilated cardiomyopathy	0.000123	0.00197	CcSEcCtD
Propafenone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000123	0.00197	CcSEcCtD
Propafenone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000122	0.00196	CcSEcCtD
Propafenone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000122	0.00196	CcSEcCtD
Propafenone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000121	0.00195	CcSEcCtD
Propafenone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000121	0.00194	CcSEcCtD
Propafenone—Carvedilol—ADRB1—dilated cardiomyopathy	0.00012	0.0298	CrCbGaD
Propafenone—Asthenia—Furosemide—dilated cardiomyopathy	0.000119	0.00192	CcSEcCtD
Propafenone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000119	0.00191	CcSEcCtD
Propafenone—Pruritus—Furosemide—dilated cardiomyopathy	0.000118	0.00189	CcSEcCtD
Propafenone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000117	0.00187	CcSEcCtD
Propafenone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000114	0.00183	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000114	0.00183	CcSEcCtD
Propafenone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000113	0.00181	CcSEcCtD
Propafenone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000112	0.0018	CcSEcCtD
Propafenone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000111	0.00179	CcSEcCtD
Propafenone—Somnolence—Lisinopril—dilated cardiomyopathy	0.000111	0.00178	CcSEcCtD
Propafenone—Dizziness—Furosemide—dilated cardiomyopathy	0.00011	0.00177	CcSEcCtD
Propafenone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00011	0.00176	CcSEcCtD
Propafenone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000109	0.00174	CcSEcCtD
Propafenone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000108	0.00173	CcSEcCtD
Propafenone—Fatigue—Lisinopril—dilated cardiomyopathy	0.000108	0.00173	CcSEcCtD
Propafenone—Constipation—Lisinopril—dilated cardiomyopathy	0.000107	0.00171	CcSEcCtD
Propafenone—Pain—Lisinopril—dilated cardiomyopathy	0.000107	0.00171	CcSEcCtD
Propafenone—Vomiting—Furosemide—dilated cardiomyopathy	0.000106	0.0017	CcSEcCtD
Propafenone—Rash—Furosemide—dilated cardiomyopathy	0.000105	0.00168	CcSEcCtD
Propafenone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000105	0.00168	CcSEcCtD
Propafenone—Headache—Furosemide—dilated cardiomyopathy	0.000104	0.00167	CcSEcCtD
Propafenone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000103	0.00165	CcSEcCtD
Propafenone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000102	0.00164	CcSEcCtD
Propafenone—Carvedilol—ADRB2—dilated cardiomyopathy	0.000101	0.0251	CrCbGaD
Propafenone—Urticaria—Lisinopril—dilated cardiomyopathy	9.92e-05	0.00159	CcSEcCtD
Propafenone—Nausea—Furosemide—dilated cardiomyopathy	9.88e-05	0.00159	CcSEcCtD
Propafenone—Body temperature increased—Lisinopril—dilated cardiomyopathy	9.87e-05	0.00158	CcSEcCtD
Propafenone—Abdominal pain—Lisinopril—dilated cardiomyopathy	9.87e-05	0.00158	CcSEcCtD
Propafenone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	9.2e-05	0.00148	CcSEcCtD
Propafenone—Propranolol—ADRB1—dilated cardiomyopathy	9.15e-05	0.0227	CrCbGaD
Propafenone—Asthenia—Lisinopril—dilated cardiomyopathy	8.96e-05	0.00144	CcSEcCtD
Propafenone—Pruritus—Lisinopril—dilated cardiomyopathy	8.83e-05	0.00142	CcSEcCtD
Propafenone—Diarrhoea—Lisinopril—dilated cardiomyopathy	8.54e-05	0.00137	CcSEcCtD
Propafenone—Dizziness—Lisinopril—dilated cardiomyopathy	8.26e-05	0.00132	CcSEcCtD
Propafenone—Vomiting—Lisinopril—dilated cardiomyopathy	7.94e-05	0.00127	CcSEcCtD
Propafenone—Rash—Lisinopril—dilated cardiomyopathy	7.87e-05	0.00126	CcSEcCtD
Propafenone—Dermatitis—Lisinopril—dilated cardiomyopathy	7.87e-05	0.00126	CcSEcCtD
Propafenone—Headache—Lisinopril—dilated cardiomyopathy	7.82e-05	0.00126	CcSEcCtD
Propafenone—Phenoxybenzamine—ADRB2—dilated cardiomyopathy	7.8e-05	0.0193	CrCbGaD
Propafenone—Propranolol—ADRB2—dilated cardiomyopathy	7.69e-05	0.0191	CrCbGaD
Propafenone—Nausea—Lisinopril—dilated cardiomyopathy	7.42e-05	0.00119	CcSEcCtD
Propafenone—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	5.88e-06	0.0766	CbGpPWpGaD
Propafenone—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	5.24e-06	0.0682	CbGpPWpGaD
Propafenone—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	4.46e-06	0.058	CbGpPWpGaD
Propafenone—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	4.46e-06	0.058	CbGpPWpGaD
Propafenone—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	4.22e-06	0.0549	CbGpPWpGaD
Propafenone—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	3.97e-06	0.0517	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	2.4e-06	0.0313	CbGpPWpGaD
Propafenone—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	2.23e-06	0.029	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	1.77e-06	0.023	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	1.71e-06	0.0223	CbGpPWpGaD
Propafenone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	1.71e-06	0.0222	CbGpPWpGaD
Propafenone—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	1.49e-06	0.0194	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	1.3e-06	0.0169	CbGpPWpGaD
Propafenone—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	1.25e-06	0.0163	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	1.16e-06	0.0152	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	1.13e-06	0.0148	CbGpPWpGaD
Propafenone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	1e-06	0.013	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	9.73e-07	0.0127	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	9.64e-07	0.0126	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	9.39e-07	0.0122	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	9.32e-07	0.0121	CbGpPWpGaD
Propafenone—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	8.47e-07	0.011	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	7.75e-07	0.0101	CbGpPWpGaD
Propafenone—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	7.68e-07	0.00999	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	6.9e-07	0.00898	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	6.68e-07	0.0087	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5.98e-07	0.00779	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	5.82e-07	0.00758	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5.8e-07	0.00755	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.4e-07	0.00703	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	5.17e-07	0.00673	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	4.83e-07	0.00629	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	4.55e-07	0.00592	CbGpPWpGaD
Propafenone—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	4.46e-07	0.00581	CbGpPWpGaD
Propafenone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.39e-07	0.00572	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	4.16e-07	0.00541	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	4.06e-07	0.00529	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	3.94e-07	0.00514	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	3.91e-07	0.00509	CbGpPWpGaD
Propafenone—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.75e-07	0.00489	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.67e-07	0.00477	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	3.64e-07	0.00474	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	3.52e-07	0.00459	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	3.41e-07	0.00443	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.38e-07	0.0044	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.38e-07	0.0044	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.34e-07	0.00435	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.17e-07	0.00412	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.14e-07	0.00409	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.14e-07	0.00409	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.05e-07	0.00398	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.03e-07	0.00395	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	2.93e-07	0.00381	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.88e-07	0.00375	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.72e-07	0.00354	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	2.6e-07	0.00339	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.6e-07	0.00338	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.57e-07	0.00335	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.57e-07	0.00335	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.56e-07	0.00333	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.47e-07	0.00321	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	2.44e-07	0.00318	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.39e-07	0.00312	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.32e-07	0.00302	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.28e-07	0.00296	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	2.22e-07	0.00289	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.21e-07	0.00287	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.18e-07	0.00284	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	2.12e-07	0.00276	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	2.09e-07	0.00272	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	1.98e-07	0.00258	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.97e-07	0.00257	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	1.94e-07	0.00253	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.92e-07	0.0025	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.92e-07	0.0025	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.88e-07	0.00244	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.83e-07	0.00238	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.78e-07	0.00232	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.67e-07	0.00218	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.67e-07	0.00218	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.59e-07	0.00208	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.59e-07	0.00208	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.56e-07	0.00203	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.51e-07	0.00196	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	1.49e-07	0.00194	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.48e-07	0.00192	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.45e-07	0.00189	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.45e-07	0.00189	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	1.4e-07	0.00182	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.39e-07	0.00181	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	1.39e-07	0.0018	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.35e-07	0.00176	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	1.33e-07	0.00173	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.32e-07	0.00172	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.32e-07	0.00172	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.3e-07	0.00169	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.3e-07	0.00169	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.26e-07	0.00165	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.23e-07	0.0016	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.22e-07	0.00159	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.22e-07	0.00159	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.21e-07	0.00158	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.15e-07	0.00149	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.14e-07	0.00148	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.12e-07	0.00146	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.1e-07	0.00143	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.06e-07	0.00138	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.04e-07	0.00135	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.03e-07	0.00135	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.03e-07	0.00134	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.02e-07	0.00132	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.79e-08	0.00128	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	9.73e-08	0.00127	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.63e-08	0.00125	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	9.5e-08	0.00124	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	9.05e-08	0.00118	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	8.8e-08	0.00115	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.79e-08	0.00114	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.24e-08	0.00107	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.98e-08	0.00104	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.87e-08	0.00102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.8e-08	0.00102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.8e-08	0.00102	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.71e-08	0.001	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.51e-08	0.000978	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.51e-08	0.000977	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.48e-08	0.000974	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.25e-08	0.000944	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.15e-08	0.000931	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.79e-08	0.000884	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.76e-08	0.000881	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.72e-08	0.000875	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.4e-08	0.000833	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.28e-08	0.000818	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.11e-08	0.000796	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6e-08	0.000781	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.69e-08	0.000741	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.51e-08	0.000717	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.37e-08	0.000699	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.23e-08	0.00068	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.96e-08	0.000646	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.89e-08	0.000637	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.7e-08	0.000613	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.42e-08	0.000575	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	4.22e-08	0.00055	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.89e-08	0.000506	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.44e-08	0.000447	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.4e-08	0.000443	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.35e-08	0.000436	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.01e-08	0.000392	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.99e-08	0.00039	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.93e-08	0.000381	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.91e-08	0.00038	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.82e-08	0.000367	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.8e-08	0.000364	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.75e-08	0.000358	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.72e-08	0.000355	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.62e-08	0.000342	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.47e-08	0.000322	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.45e-08	0.000319	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.39e-08	0.000311	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.33e-08	0.000303	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.1e-08	0.000273	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.01e-08	0.000262	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.84e-08	0.00024	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.8e-08	0.000234	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.62e-08	0.000211	CbGpPWpGaD
